CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...